HEADER CHAPERONE 10-DEC-10 2Y1Y TITLE HUMAN ALPHAB CRYSTALLIN ACD(RESIDUES 71-157) COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-CRYSTALLIN B CHAIN,; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ALPHA-CRYSTALLIN DOMAIN (ACD), RESIDUES 71-157; COMPND 5 SYNONYM: ALPHAB-CRYSTALLIN, ALPHA(B)-CRYSTALLIN, HEAT SHOCK PROTEIN COMPND 6 BETA-5, HSPB5, RENAL CARCINOMA ANTIGEN NY-REN-27, ROSENTHAL FIBER COMPND 7 COMPONENT; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 OTHER_DETAILS: SELENOMETHIONE CONTAINING PROTEIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PPROEX HT(B) KEYWDS SMALL HEAT SHOCK PROTEIN, CHAPERONE, STRESS PROTEIN, EYE LENS KEYWDS 2 PROTEIN, CATARACT EXPDTA X-RAY DIFFRACTION AUTHOR C.E.NAYLOR,C.BAGNERIS,A.R.CLARK,N.H.KEEP,C.SLINGSBY REVDAT 3 08-MAY-19 2Y1Y 1 REMARK LINK REVDAT 2 13-APR-11 2Y1Y 1 JRNL REVDAT 1 02-MAR-11 2Y1Y 0 JRNL AUTH A.R.CLARK,C.E.NAYLOR,C.BAGNERIS,N.H.KEEP,C.SLINGSBY JRNL TITL CRYSTAL STRUCTURE OF R120G DISEASE MUTANT OF HUMAN JRNL TITL 2 ALPHAB-CRYSTALLIN DOMAIN DIMER SHOWS CLOSURE OF A GROOVE JRNL REF J.MOL.BIOL. V. 408 118 2011 JRNL REFN ISSN 0022-2836 JRNL PMID 21329698 JRNL DOI 10.1016/J.JMB.2011.02.020 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.BAGNERIS,O.A.BATEMAN,C.E.NAYLOR,N.CRONIN,W.C.BOELENS, REMARK 1 AUTH 2 N.H.KEEP,C.SLINGSBY REMARK 1 TITL CRYSTAL STRUCTURES OF ALPHA-CRYSTALLIN DOMAIN DIMERS OF REMARK 1 TITL 2 ALPHAB-CRYSTALLIN AND HSP20. REMARK 1 REF J.MOL.BIOL. V. 392 1242 2009 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 19646995 REMARK 1 DOI 10.1016/J.JMB.2009.07.069 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.01 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 7272 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 588 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.0171 - 3.1743 1.00 2984 162 0.2055 0.2093 REMARK 3 2 3.1743 - 2.5197 1.00 3005 145 0.2091 0.2484 REMARK 3 3 2.5197 - 2.2013 1.00 3034 123 0.1998 0.2492 REMARK 3 4 2.2013 - 2.0000 1.00 2971 158 0.1848 0.1808 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.34 REMARK 3 B_SOL : 54.58 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.400 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.18940 REMARK 3 B22 (A**2) : 3.18940 REMARK 3 B33 (A**2) : -6.37880 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 638 REMARK 3 ANGLE : 0.673 866 REMARK 3 CHIRALITY : 0.049 95 REMARK 3 PLANARITY : 0.003 114 REMARK 3 DIHEDRAL : 14.180 240 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A AND RESID 1:58 REMARK 3 ORIGIN FOR THE GROUP (A): -16.6765 14.6408 11.6912 REMARK 3 T TENSOR REMARK 3 T11: 0.1515 T22: 0.1684 REMARK 3 T33: 0.0840 T12: 0.1195 REMARK 3 T13: -0.0005 T23: -0.0012 REMARK 3 L TENSOR REMARK 3 L11: 0.5863 L22: 0.5387 REMARK 3 L33: 2.8965 L12: -0.0504 REMARK 3 L13: -0.4371 L23: 0.6533 REMARK 3 S TENSOR REMARK 3 S11: 0.0052 S12: 0.1148 S13: -0.1072 REMARK 3 S21: -0.2119 S22: -0.1405 S23: 0.0473 REMARK 3 S31: -0.2641 S32: -0.0370 S33: 0.1444 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN A AND RESID 59:87 REMARK 3 ORIGIN FOR THE GROUP (A): -10.1100 2.2138 6.4863 REMARK 3 T TENSOR REMARK 3 T11: 0.2636 T22: 0.2531 REMARK 3 T33: 0.1893 T12: 0.1641 REMARK 3 T13: 0.0299 T23: 0.0147 REMARK 3 L TENSOR REMARK 3 L11: 0.5606 L22: 0.6657 REMARK 3 L33: 2.8189 L12: 0.0672 REMARK 3 L13: -0.5549 L23: 0.0955 REMARK 3 S TENSOR REMARK 3 S11: -0.3277 S12: 0.0825 S13: -0.2089 REMARK 3 S21: 0.0870 S22: 0.0600 S23: 0.0355 REMARK 3 S31: 0.8231 S32: 0.4060 S33: 0.1593 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2Y1Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-DEC-10. REMARK 100 THE DEPOSITION ID IS D_1290046622. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-MAY-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9794 REMARK 200 MONOCHROMATOR : DOUBLE SI CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7272 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 35.010 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 25.40 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 26.80 REMARK 200 R MERGE FOR SHELL (I) : 0.32000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 11.60 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2WJ7 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SITTING DROPS, 20 MG/ML PROTEIN IN 25 REMARK 280 MM TRIS, PH8.5, 200 MM NACL. EQUILIBRATED AGAINST MOTHER LIQUOR REMARK 280 OF 110 MM BICINE, PH 9.0, 40% MPD, VAPOR DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+1/4 REMARK 290 8555 -Y,-X,-Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.16000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 111.24000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 37.08000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 74.16000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 37.08000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 111.24000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9540 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -36.03000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2053 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LEU 137 TO MSE REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 68 REMARK 465 ALA A 69 REMARK 465 MSE A 70 REMARK 465 GLU A 71 REMARK 465 LYS A 72 REMARK 465 GLN A 151 REMARK 465 VAL A 152 REMARK 465 SER A 153 REMARK 465 GLY A 154 REMARK 465 PRO A 155 REMARK 465 GLU A 156 REMARK 465 ARG A 157 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 74 CD NE CZ NH1 NH2 REMARK 470 GLU A 87 CD OE1 OE2 REMARK 470 LYS A 90 CG CD CE NZ REMARK 470 LYS A 92 CD CE NZ REMARK 470 LEU A 94 CG CD1 CD2 REMARK 470 LYS A 103 NZ REMARK 470 ARG A 123 NE CZ NH1 NH2 REMARK 470 LYS A 150 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 74 147.71 175.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2025 DISTANCE = 5.83 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MRD A 1151 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2WJ7 RELATED DB: PDB REMARK 900 HUMAN ALPHAB CRYSTALLIN REMARK 900 RELATED ID: 2Y22 RELATED DB: PDB REMARK 900 HUMAN ALPHAB-CRYSTALLIN DOMAIN (RESIDUES 67-157) REMARK 900 RELATED ID: 2Y1Z RELATED DB: PDB REMARK 900 HUMAN ALPHAB CRYSTALLIN ACD R120G REMARK 999 REMARK 999 SEQUENCE REMARK 999 ALPHA-CRYSTALLIN DOMAIN ONLY. HUMAN ALPHAB CRYSTALLIN REMARK 999 ACD(RESIDUES 71-157). LEUCINE 137 MUTATED TO METHIONINE REMARK 999 FOR PHASING. DBREF 2Y1Y A 71 157 UNP P02511 CRYAB_HUMAN 71 157 SEQADV 2Y1Y GLY A 68 UNP P02511 EXPRESSION TAG SEQADV 2Y1Y ALA A 69 UNP P02511 EXPRESSION TAG SEQADV 2Y1Y MSE A 70 UNP P02511 EXPRESSION TAG SEQADV 2Y1Y MSE A 137 UNP P02511 LEU 137 ENGINEERED MUTATION SEQRES 1 A 90 GLY ALA MSE GLU LYS ASP ARG PHE SER VAL ASN LEU ASP SEQRES 2 A 90 VAL LYS HIS PHE SER PRO GLU GLU LEU LYS VAL LYS VAL SEQRES 3 A 90 LEU GLY ASP VAL ILE GLU VAL HIS GLY LYS HIS GLU GLU SEQRES 4 A 90 ARG GLN ASP GLU HIS GLY PHE ILE SER ARG GLU PHE HIS SEQRES 5 A 90 ARG LYS TYR ARG ILE PRO ALA ASP VAL ASP PRO LEU THR SEQRES 6 A 90 ILE THR SER SER MSE SER SER ASP GLY VAL LEU THR VAL SEQRES 7 A 90 ASN GLY PRO ARG LYS GLN VAL SER GLY PRO GLU ARG MODRES 2Y1Y MSE A 137 MET SELENOMETHIONINE HET MSE A 137 13 HET MRD A1151 8 HETNAM MSE SELENOMETHIONINE HETNAM MRD (4R)-2-METHYLPENTANE-2,4-DIOL FORMUL 1 MSE C5 H11 N O2 SE FORMUL 2 MRD C6 H14 O2 FORMUL 3 HOH *63(H2 O) HELIX 1 1 SER A 85 GLU A 87 5 3 HELIX 2 2 ASP A 129 ILE A 133 5 5 SHEET 1 AA 3 PHE A 75 ASP A 80 0 SHEET 2 AA 3 VAL A 142 GLY A 147 -1 O LEU A 143 N LEU A 79 SHEET 3 AA 3 THR A 134 MSE A 137 -1 O THR A 134 N ASN A 146 SHEET 1 AB 3 LEU A 89 LEU A 94 0 SHEET 2 AB 3 VAL A 97 GLN A 108 -1 O VAL A 97 N LEU A 94 SHEET 3 AB 3 PHE A 113 ARG A 123 -1 O ILE A 114 N ARG A 107 LINK C SER A 136 N MSE A 137 1555 1555 1.33 LINK C MSE A 137 N SER A 138 1555 1555 1.33 SITE 1 AC1 5 LEU A 89 SER A 135 SER A 136 MSE A 137 SITE 2 AC1 5 HOH A2063 CRYST1 36.030 36.030 148.320 90.00 90.00 90.00 P 43 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027755 0.000000 0.000000 0.00000 SCALE2 0.000000 0.027755 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006742 0.00000